Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Invested Capital: 2009-2024

Historic Invested Capital for Ani Pharmaceuticals (ANIP) over the last 16 years, with Dec 2024 value amounting to $726.6 million.

  • Ani Pharmaceuticals' Invested Capital fell 1.58% to $822.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $822.7 million, marking a year-over-year decrease of 1.58%. This contributed to the annual value of $726.6 million for FY2024, which is 10.08% down from last year.
  • As of FY2024, Ani Pharmaceuticals' Invested Capital stood at $726.6 million, which was down 10.08% from $808.1 million recorded in FY2023.
  • In the past 5 years, Ani Pharmaceuticals' Invested Capital registered a high of $808.1 million during FY2023, and its lowest value of $327.9 million during FY2020.
  • For the 3-year period, Ani Pharmaceuticals' Invested Capital averaged around $745.2 million, with its median value being $726.6 million (2024).
  • In the last 5 years, Ani Pharmaceuticals' Invested Capital spiked by 109.75% in 2021 and then decreased by 10.08% in 2024.
  • Ani Pharmaceuticals' Invested Capital (Yearly) stood at $327.9 million in 2020, then spiked by 109.75% to $687.8 million in 2021, then increased by 1.90% to $700.9 million in 2022, then grew by 15.29% to $808.1 million in 2023, then fell by 10.08% to $726.6 million in 2024.